Haleon plc ADRHLN
Price$8.72Intrinsic value$13.5656% above price

Valuation

How Intrinsic Value compares with model outputs

Intrinsic Value $13.56median of 6 methods · middle span $12-$27based on filings through 31 Dec 2025
Market Price $8.72Price as of 1 Oct 2026
Margin of Safety +55.6%as of 1 Oct 2026

Valuation methods vs. Market Price

Company vs. peer median Members

This section is available to registered members. Create a free account or sign in to unlock the full breakdown.

Sign in / Sign up

Assumptions

ParameterValue
Years 1–5: analyst growth pathFive-year total matches analyst consensus exactly. Year 1: 9.5% (near-term consensus, capped) · years 2–5: 9.6%/yr (balance of the path).9.6% per year
Years 6–10: glide to demonstrated growth
Per-year rates
Yr 69.3%Yr 79.1%Yr 88.8%Yr 98.6%Yr 108.3%
9.6% → 8.3%
Years 11–20: glide to long-run rate
Per-year rates
Yr 117.8%Yr 127.3%Yr 136.7%Yr 146.2%Yr 155.7%Yr 165.1%Yr 174.6%Yr 184.1%Yr 193.5%Yr 203.0%
8.3% → 3.0%
Beyond year 20: terminal growthPerpetual long-run rate3.0%
Historical EPS growth (multi-year median)median of 1 window (5y) (limited history)8.3%
Discount rate (cost of equity) 6.8%
Volatility vs market (adjusted beta)0.41

Valuation Detail Members

This section is available to registered members. Create a free account or sign in to unlock the full breakdown.

Sign in / Sign up

Assumptions Sandbox Members

This section is available to registered members. Create a free account or sign in to unlock the full breakdown.

Sign in / Sign up

Compare with peers

Search any company to compare valuation, profitability, returns, growth, and financial strength side by side.

Compare the target company plus 1 peer. Sign in / Sign up to compare a maximum of 3 peers.

Best in rowHigher is betterLower is better—Data not available
TargetHaleon plc ADRHLNHealth Care
Valuation
P/E—
P/S3.7×
P/B5.1×
EV / Revenue3.6×
EV / EBITDA—
Profitability
Gross margin—
Operating margin21.9%
Net margin15.1%
FCF margin21.0%
Returns
ROE10.1%
ROA5.1%
ROIC—
Growth
Revenue growth (YoY)5.5%
5-yr fwd EPS growth9.6%
Financial strength
Debt / Equity—
Current ratio0.92×
Altman Z-Score—
Interest coverage—
Dividend yield1.4%

Best value in each row is highlighted. Figures are periodic snapshots from the same filings used across each dossier; a dash means the figure is not available.

AI-assisted, source-linked narrative; figures from company filings (SEC EDGAR) and market data. Dates shown per section. Not investment advice. Terms of Use.